{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:36:14Z","timestamp":1793637374674,"version":"4.5.1"},"reference-count":25,"publisher":"Japan Neurosurgical Society","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.2176\/jns-nmc.2023-0289","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T22:12:42Z","timestamp":1713910362000},"page":"119-123","source":"Crossref","is-referenced-by-count":4,"title":["A Case of Rheumatoid Meningitis Diagnosed with FLAIR Images and Anti-cyclic Citrullinated Peptide Antibodies Levels"],"prefix":"10.2176","volume":"11","author":[{"given":"Taro","family":"SUZUKI","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Iwate Prefectural Ofunato Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"AKAMATSU","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotaro","family":"OSHIDA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Iwate Prefectural Ofunato Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinpei","family":"SATO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Iwate Prefectural Ofunato Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Parsons AM, Aslam F, Grill MF, Aksamit A, Goodman BP: Rheumatoid meningitis: clinical characteristics, diagnostic evaluation, and treatment. <i>Neurohospitalist<\/i> 10: 88-94, 2020","DOI":"10.1177\/1941874419859769"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Nissen MS, Nilsson AC, Forsberg J, et al.: Use of cerebrospinal fluid biomarkers in diagnosis and monitoring of rheumatoid meningitis. <i>Front Neurol<\/i> 10: 666, 2019","DOI":"10.3389\/fneur.2019.00666"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Mahendru G, Chong V: Meninges in cancer imaging. <i>Cancer Imaging<\/i> 9: S14-S21, 2009","DOI":"10.1102\/1470-7330.2009.9004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Choi SJ, Park YO, Kim JA, Han JH, Choe G, Kim SY: Pearls &amp; Oy-sters: asymmetric meningeal involvement is a common feature of rheumatoid meningitis. <i>Neurology<\/i> 88: e108-e110, 2017","DOI":"10.1212\/WNL.0000000000003744"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mehta SH, Switzer JA, Biddinger P, Rojiani AM: IgG4-related leptomeningitis: a reversible cause of rapidly progressive cognitive decline. <i>Neurology<\/i> 82: 540-542, 2014","DOI":"10.1212\/WNL.0000000000000100"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Caputi L, Boncoraglio GB, Bernardi G, et al.: Anti-cyclic citrullinated peptide antibody index in the cerebrospinal fluid for the diagnosis and monitoring of rheumatoid meningitis. <i>Biomedicines<\/i> 10: 2401, 2022","DOI":"10.3390\/biomedicines10102401"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Reiber H, Peter JB: Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. <i>J Neurol Sci<\/i> 184: 101-122, 2001","DOI":"10.1016\/S0022-510X(00)00501-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Joshi S, Masiak A, Zdrojewski Z: Rheumatoid arthritis with pachymeningitis - a case presentation and review of the literature. <i>Reumatologia<\/i> 58: 116-122, 2020","DOI":"10.5114\/reum.2020.95368"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Manolios E, Manolios N, Spencer D: Leptomeningitis in rheumatoid arthritis. <i>Eur J Rheumatol<\/i> 8: 48-50, 2021","DOI":"10.5152\/eurjrheum.2020.20063"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Matsuura D, Ohshita T, Nagano Y, Ohtsuki T, Kohriyama T, Matsumoto M: [Case of rheumatoid meningitis: findings on diffusion-weighted image versus FLAIR image]. <i>Rinsho Shinkeigaku<\/i> 48: 191-195, 2008 (Japanese)","DOI":"10.5692\/clinicalneurol.48.191"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Shimada K, Matsui T, Kawakami M, et al.: Diffuse chronic leptomeningitis with seropositive rheumatoid arthritis: report of a case successfully treated as rheumatoid leptomeningitis. <i>Mod Rheumatol<\/i> 19: 556-562, 2009","DOI":"10.1007\/s10165-009-0186-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Lee EK, Lee EJ, Kim S, Lee YS: Importance of contrast-enhanced fluid-attenuated inversion recovery magnetic resonance imaging in various intracranial pathologic conditions. <i>Korean J Radiol<\/i> 17: 127-141, 2016","DOI":"10.3348\/kjr.2016.17.1.127"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Jin T, Ge M, Huang R, et al.: Utility of contrast-enhanced T2 FLAIR for imaging brain metastases using a half-dose high-relaxivity contrast agent. <i>AJNR Am J Neuroradiol<\/i> 42: 457-463, 2021","DOI":"10.3174\/ajnr.A6931"},{"key":"14","unstructured":"14) Roozpeykar S, Azizian M, Zamani Z, et al.: Contrast-enhanced weighted-T1 and FLAIR sequences in MRI of meningeal lesions. <i>Am J Nucl Med Mol Imaging<\/i> 12: 63-70, 2022"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Vaswani AK, Nizamani WM, Ali M, Aneel G, Shahari BK, Hussain S: Diagnostic accuracy of contrast-enhanced FLAIR magnetic resonance imaging in diagnosis of meningitis correlated with CSF analysis. <i>ISRN Radiol<\/i> 2014: 578986, 2014","DOI":"10.1155\/2014\/578986"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Fukuoka H, Hirai T, Okuda T, et al.: Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T. <i>AJNR Am J Neuroradiol<\/i> 31: 868-873, 2010","DOI":"10.3174\/ajnr.A1937"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Fan S, Zhao J, Hou B, et al.: Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis. <i>Front Immunol<\/i> 14: 1065650, 2023","DOI":"10.3389\/fimmu.2023.1065650"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Qin Z, Kim J, Valencia D, et al.: Rheumatoid meningitis: a case report and review of the literature. <i>Neurol Clin Pract<\/i> 10: 73-83, 2020","DOI":"10.1212\/CPJ.0000000000000678"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ikeda K, Takazawa T, Ito H, et al.: Rheumatoid leptomeningitis: radiological alteration of cerebral hypoperfusion and subarachnoid lesions. <i>Intern Med<\/i> 49: 1911-1916, 2010","DOI":"10.2169\/internalmedicine.49.3492"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Mekic M, Hadzigrahic E: Anti-cyclic citrullinated peptide antibody as a predictor of rheumathoid arthritis complications. <i>Med Arch<\/i> 74: 183-186, 2020","DOI":"10.5455\/medarh.2020.74.183-186"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Lee DW, Gardner R, Porter DL, et al.: Current concepts in the diagnosis and management of cytokine release syndrome. <i>Blood<\/i> 124: 188-195, 2014","DOI":"10.1182\/blood-2014-05-552729"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Bihan K, Weiss N, Theophile H, Funck-Brentano C, Lebrun-Vignes B: Drug-induced aseptic meningitis: 329 cases from the French pharmacovigilance database analysis. <i>Br J Clin Pharmacol<\/i> 85: 2540-2546, 2019","DOI":"10.1111\/bcp.14073"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Dougados M, Kissel K, Sheeran T, et al.: Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomized controlled strategy trial in rheumatoid arthritis (ACT-RAY). <i>Ann Rheum Dis<\/i> 72: 43-50, 2013","DOI":"10.1136\/annrheumdis-2011-201282"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Humby F, Durez P, Buch MH, et al.: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. <i>Lancet<\/i> 397: 305-317, 2021","DOI":"10.1016\/S0140-6736(20)32341-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Prince EW, Hoffman LM, Vijmasi T, et al.: Adamantinomatous craniopharyngioma associated with a compromised blood-brain barrier: patient series. <i>J Neurosurg Case Lessons<\/i> 1: CASE2150, 2021","DOI":"10.3171\/CASE2150"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/11\/0\/11_2023-0289\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T05:15:52Z","timestamp":1714194952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/11\/0\/11_2023-0289\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":25,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2023-0289","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,31]]},"article-number":"2023-0289"}}